Cause-specific mortality in patients with chronic pancreatitis: a nationwide population-based cohort study.
코호트
2/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
565 patients (mean age 59 years; 64% male) followed for a median of 10.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Early deaths are driven by pancreatitis-related deaths and liver disease, whereas extra-pancreatic cancers, respiratory, and cardiovascular deaths become more prominent later. [FUNDING] This study was not funded.
OpenAlex 토픽 ·
Pancreatitis Pathology and Treatment
Pancreatic and Hepatic Oncology Research
Gallbladder and Bile Duct Disorders
[BACKGROUND] Chronic pancreatitis is associated with high mortality, but evidence on the causes of death is limited.
- 연구 설계 cohort study
APA
Line Davidsen, Niels Henrik Bruun, et al. (2026). Cause-specific mortality in patients with chronic pancreatitis: a nationwide population-based cohort study.. European journal of internal medicine, 106874. https://doi.org/10.1016/j.ejim.2026.106874
MLA
Line Davidsen, et al.. "Cause-specific mortality in patients with chronic pancreatitis: a nationwide population-based cohort study.." European journal of internal medicine, 2026, pp. 106874.
PMID
41966906 ↗
Abstract 한글 요약
[BACKGROUND] Chronic pancreatitis is associated with high mortality, but evidence on the causes of death is limited. We investigated cause-specific mortality, including cancer-related deaths, over a 20-year period following chronic pancreatitis diagnosis.
[METHODS] Using Danish national health registries, we conducted a nationwide cohort study of incident adult (>18 years) chronic pancreatitis cases from 2002 to 2022. Patients were followed from diagnosis until death or the end of follow-up. Cause-specific mortality was estimated using cumulative incidence functions accounting for competing risks.
[FINDINGS] Among 14,565 patients (mean age 59 years; 64% male) followed for a median of 10.2 years, 7001 (48%) died. In the first 5 years after chronic pancreatitis diagnosis, the leading causes of death were pancreatitis-related, pancreatic cancer, and liver disease, with corresponding 5-year cumulative incidences of 4.5%, 3.4%, and 4.4%, respectively. Beyond 5 years, deaths from extra-pancreatic cancers, respiratory, and cardiovascular disease became more common with corresponding 20-year cumulative risk incidences of 13.4%, 6.1% and 7.0%, respectively. Among cancer deaths, pancreatic cancer predominated early, whereas lung cancer became the leading cause of cancer-related deaths after 5 years. In sensitivity analyses with a 2-year lag between chronic pancreatitis and pancreatic cancer diagnosis, the 5-year cumulative pancreatic cancer incidence decreased from 3.4% to 0.5%, indicating misclassification of early pancreatic cancers.
[INTERPRETATION] Cause-specific mortality in chronic pancreatitis changes over time. Early deaths are driven by pancreatitis-related deaths and liver disease, whereas extra-pancreatic cancers, respiratory, and cardiovascular deaths become more prominent later.
[FUNDING] This study was not funded.
[METHODS] Using Danish national health registries, we conducted a nationwide cohort study of incident adult (>18 years) chronic pancreatitis cases from 2002 to 2022. Patients were followed from diagnosis until death or the end of follow-up. Cause-specific mortality was estimated using cumulative incidence functions accounting for competing risks.
[FINDINGS] Among 14,565 patients (mean age 59 years; 64% male) followed for a median of 10.2 years, 7001 (48%) died. In the first 5 years after chronic pancreatitis diagnosis, the leading causes of death were pancreatitis-related, pancreatic cancer, and liver disease, with corresponding 5-year cumulative incidences of 4.5%, 3.4%, and 4.4%, respectively. Beyond 5 years, deaths from extra-pancreatic cancers, respiratory, and cardiovascular disease became more common with corresponding 20-year cumulative risk incidences of 13.4%, 6.1% and 7.0%, respectively. Among cancer deaths, pancreatic cancer predominated early, whereas lung cancer became the leading cause of cancer-related deaths after 5 years. In sensitivity analyses with a 2-year lag between chronic pancreatitis and pancreatic cancer diagnosis, the 5-year cumulative pancreatic cancer incidence decreased from 3.4% to 0.5%, indicating misclassification of early pancreatic cancers.
[INTERPRETATION] Cause-specific mortality in chronic pancreatitis changes over time. Early deaths are driven by pancreatitis-related deaths and liver disease, whereas extra-pancreatic cancers, respiratory, and cardiovascular deaths become more prominent later.
[FUNDING] This study was not funded.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study.
- LCMS-Net: Deep Learning for Raw High Resolution Mass Spectrometry Data Applied to Forensic Cause-of-Death Screening.
- Disentangling Links Between Lung Cancer and Infectious Pneumonia via Real-World Data and Integrative Genomics.
- Association of Patient Comorbidities With Treatment Regret Among Patients With Localized Prostate Cancer - Results From a Population-Based Cohort.
- Global and National Burden of Chronic Obstructive Pulmonary Disease and Tracheal, Bronchus, and Lung Cancer From 1990 to 2021: Comorbidity Burden Analysis Based on the Global Burden of Disease Study 2021.
- The relationship between chronic stress, co-occurring conditions, sleep, and autistic features including severity using hair cortisol concentration.